Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT01308567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open Label, Multi-Center Study Comparing Cabazitaxel at 25 mg/m^2 and at 20 mg/m^2 in Combination With Prednisone Every 3 Weeks to Docetaxel in Combination With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Not Pretreated With Chemotherapy
Study identification
- NCT ID
- NCT01308567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 1,168 participants
Conditions and interventions
Conditions
Interventions
- Cabazitaxel (XRP6258) Drug
- Docetaxel (XRP6976) Drug
- Prednisone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2011
- Primary completion
- Aug 31, 2015
- Completion
- Apr 30, 2018
- Last update posted
- Jun 4, 2019
2011 – 2018
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840004 | Muscle Shoals | Alabama | 35661 | — |
| Investigational Site Number 840009 | Anaheim | California | 92801 | — |
| Investigational Site Number 840014 | Bakersfield | California | 93309 | — |
| Investigational Site Number 840030 | Sacramento | California | 95816 | — |
| Investigational Site Number 840003 | San Bernardino | California | 92404 | — |
| Investigational Site Number 840012 | San Francisco | California | 94143 | — |
| Investigational Site Number 840019 | Denver | Colorado | 80262 | — |
| Investigational Site Number 840013 | Boca Raton | Florida | 33486 | — |
| Investigational Site Number 840035 | Jacksonville | Florida | 32256 | — |
| Investigational Site Number 840001 | Port Saint Lucie | Florida | 34952 | — |
| Investigational Site Number 840015 | Decatur | Illinois | 62526 | — |
| Investigational Site Number 840018 | Wichita | Kansas | 67214 | — |
| Investigational Site Number 840010 | Paducah | Kentucky | 42002 | — |
| Investigational Site Number 840008 | New Orleans | Louisiana | 70112 | — |
| Investigational Site Number 840006 | Rockville | Maryland | 20850 | — |
| Investigational Site Number 840238 | Boston | Massachusetts | 02114 | — |
| Investigational Site Number 840138 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 840038 | Brookline | Massachusetts | 02115 | — |
| Investigational Site Number 840005 | Detroit | Michigan | 48202 | — |
| Investigational Site Number 840021 | Saint Louis Park | Minnesota | 55416 | — |
| Investigational Site Number 840016 | Kansas City | Missouri | 64128 | — |
| Investigational Site Number 840020 | Lincoln | Nebraska | 68506 | — |
| Investigational Site Number 840017 | East Orange | New Jersey | 07018 | — |
| Investigational Site Number 840033 | Albuquerque | New Mexico | 87109 | — |
| Investigational Site Number 840036 | Raleigh | North Carolina | 27607 | — |
| Investigational Site Number 840011 | Washington | North Carolina | 27889 | — |
| Investigational Site Number 840026 | Akron | Ohio | 44302 | — |
| Investigational Site Number 840023 | Cleveland | Ohio | 44106 | — |
| Investigational Site Number 840032 | Dunmore | Pennsylvania | 18512 | — |
| Investigational Site Number 840007 | Pawtucket | Rhode Island | 02860 | — |
| Investigational Site Number 840037 | Myrtle Beach | South Carolina | 29572 | — |
| Investigational Site Number 840028 | Chattanooga | Tennessee | 37421 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01308567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01308567 live on ClinicalTrials.gov.